Altimmune Balance Sheet Health
Financial Health criteria checks 6/6
Altimmune has a total shareholder equity of $172.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $188.4M and $15.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$182.02m |
Equity | US$172.94m |
Total liabilities | US$15.42m |
Total assets | US$188.36m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A4C's short term assets ($187.5M) exceed its short term liabilities ($11.3M).
Long Term Liabilities: 0A4C's short term assets ($187.5M) exceed its long term liabilities ($4.1M).
Debt to Equity History and Analysis
Debt Level: 0A4C is debt free.
Reducing Debt: 0A4C has no debt compared to 5 years ago when its debt to equity ratio was 0.9%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0A4C has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0A4C has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 31.7% each year.